AXOVANT announces clinical update from first Tay-Sachs disease patient dosed with AXO-AAV-GM2 gene therapy
March 11, 2019

Generally well-tolerated with no serious adverse events in a 30-month-old patient with advanced infantile Tay-Sachs...

New blood test detects genetic disorders in fetuses
February 21, 2019

Tel Aviv University researchers have developed a new blood test for genetic disorders that may...

UMMS licenses clinical-stage gene therapies for Tay-Sachs, similar diseases to Axovant
December 13, 2018

Axovant Sciences, a Swiss company developing innovative gene therapies for serious neurological diseases, has licensed...

New Approaches to Tay-Sachs Disease Therapy
November 20, 2018

Tay-Sachs disease belongs to the group of autosomal-recessive lysosomal storage metabolic disorders. This disease is...

Tay Sachs Sees Hope in First Gene Therapy Clinical Trial

Blu Genes Foundation Gives UMMS $1.4M(USD) to Bring Tay-Sachs Gene Therapy Approach to Clinical Trial...

06
Nov
Twin Sisters Share a Diagnosis -Tay-Sachs Disease – and a Desire to Make a Difference
January 30, 2018

Katie and Allie Buryk lived with strange symptoms for years before learning they had Tay-Sachs...

How Jewish activism has virtually wiped out Tay-Sachs
August 23, 2017

Thanks to technology and an aggressive screening campaign, the genetic disease is all but gone...

Tay-Sachs Children Respond to Ground-Breaking Stem Cell Gene Therapy
April 26, 2011

SARASOTA, FL–(Marketwire – 04/26/11) – StemCellRegenMed today announces, as a result of its continued ground-breaking...

BC Researchers Aid Effort To End Tay-Sachs Disease
February 25, 2008

Researchers from Boston College, Massachusetts General Hospital, Cambridge University (UK) and Auburn University have formed...